PHAF DIC Team

Approval of new treatment for adults with partial-onset seizures

​

PHAF Team

Apremilast approved for oral ulcers associated with Behçet’s Disease

​

PHAF Team

AirDuo Digihaler got green signal from FDA

​

PHAF DIC Team

Crizanlizumab-tmca approved for sickle cell disease

​

PHAF Team

First generic drug for pain from nerve damage

​

PHAF Team

Katerzia (amlodipine) Oral Suspension Approved for Pediatric Patients 6 Years of Age and Older

​

PHAF Team

New drug for treatment-resistant forms of tuberculosis that affects the lungs

​

PHAF Team

New treatment for complicated urinary tract and complicated intra-abdominal infections

​

PHAF Team

Xpovio (selinexor) Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myelo

​